PBM
Price
$4.90
Change
-$0.25 (-4.85%)
Updated
Jul 9 closing price
Capitalization
3.49M
SLRX
Price
$0.79
Change
-$0.00 (-0.00%)
Updated
Jul 9 closing price
Capitalization
1.61M
Interact to see
Advertisement

PBM vs SLRX

Header iconPBM vs SLRX Comparison
Open Charts PBM vs SLRXBanner chart's image
Psyence Biomedical
Price$4.90
Change-$0.25 (-4.85%)
Volume$17.14K
Capitalization3.49M
Salarius Pharmaceuticals
Price$0.79
Change-$0.00 (-0.00%)
Volume$585.27K
Capitalization1.61M
PBM vs SLRX Comparison Chart in %
Loading...
PBM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PBM vs. SLRX commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBM is a Hold and SLRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (PBM: $4.90 vs. SLRX: $0.76)
Brand notoriety: PBM and SLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PBM: 10% vs. SLRX: 67%
Market capitalization -- PBM: $3.49M vs. SLRX: $1.61M
PBM [@Biotechnology] is valued at $3.49M. SLRX’s [@Biotechnology] market capitalization is $1.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PBM’s FA Score shows that 1 FA rating(s) are green whileSLRX’s FA Score has 0 green FA rating(s).

  • PBM’s FA Score: 1 green, 4 red.
  • SLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, PBM is a better buy in the long-term than SLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PBM’s TA Score shows that 2 TA indicator(s) are bullish while SLRX’s TA Score has 3 bullish TA indicator(s).

  • PBM’s TA Score: 2 bullish, 4 bearish.
  • SLRX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, PBM is a better buy in the short-term than SLRX.

Price Growth

PBM (@Biotechnology) experienced а -13.27% price change this week, while SLRX (@Biotechnology) price change was -15.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.89%. For the same industry, the average monthly price growth was +16.25%, and the average quarterly price growth was +20.89%.

Reported Earning Dates

PBM is expected to report earnings on Jun 25, 2025.

SLRX is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+9.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PBM($3.5M) has a higher market cap than SLRX($1.61M). SLRX YTD gains are higher at: -58.908 vs. PBM (-70.862). SLRX has higher annual earnings (EBITDA): -5.68M vs. PBM (-46.56M). PBM has more cash in the bank: 1.93M vs. SLRX (1.8M). SLRX has less debt than PBM: SLRX (112K) vs PBM (2.5M). PBM (0) and SLRX (0) have equivalent revenues.
PBMSLRXPBM / SLRX
Capitalization3.5M1.61M217%
EBITDA-46.56M-5.68M820%
Gain YTD-70.862-58.908120%
P/E Ratio0.12N/A-
Revenue00-
Total Cash1.93M1.8M108%
Total Debt2.5M112K2,233%
FUNDAMENTALS RATINGS
SLRX: Fundamental Ratings
SLRX
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PBMSLRX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 9 days ago
87%
Bullish Trend 21 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PBM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WKHS2.900.19
+7.01%
Workhorse Group Inc
SXTC1.770.08
+4.73%
China SXT Pharmaceuticals Inc.
AHR36.040.34
+0.95%
American Healthcare REIT
AIZ190.500.24
+0.13%
Assurant
NEON25.18-1.22
-4.62%
Neonode

PBM and

Correlation & Price change

A.I.dvisor tells us that PBM and ATHA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PBM and ATHA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBM
1D Price
Change %
PBM100%
-4.85%
ATHA - PBM
30%
Poorly correlated
+9.32%
SLRX - PBM
29%
Poorly correlated
-4.29%
CRBU - PBM
27%
Poorly correlated
+9.37%
VKTX - PBM
25%
Poorly correlated
+0.70%
GBIO - PBM
25%
Poorly correlated
+7.23%
More

SLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLRX has been closely correlated with MBIO. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if SLRX jumps, then MBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLRX
1D Price
Change %
SLRX100%
-4.29%
MBIO - SLRX
71%
Closely correlated
+16.92%
AZTR - SLRX
38%
Loosely correlated
+9.91%
PHIO - SLRX
32%
Poorly correlated
-0.40%
NRSN - SLRX
32%
Poorly correlated
-0.48%
PBM - SLRX
29%
Poorly correlated
-4.85%
More